Literature DB >> 10520215

Expression of integrin receptors in the human trabecular meshwork.

L Zhou1, I Maruyama, Y Li, E L Cheng, B Y Yue.   

Abstract

PURPOSE: To examine the expression of integrin receptors in the human trabecular meshwork.
METHODS: The expression of integrins in human tissues was visualized by immunohistochemical staining using integrin-specific antibodies. Immunoprecipitation was performed after biotin labeling of cell surface proteins. Reverse transcriptase-polymerase chain reaction was used to detect the presence of mRNA species for integrin subunits.
RESULTS: Human trabecular meshwork tissues obtained from donors 2 to 65 years old stained positively for integrins alpha1, alpha3, alpha4, alpha5, alpha6, alphav, beta1, beta3, beta4 and beta5. The staining was observed mostly around the edges of trabecular beams in association with trabecular meshwork cells. The staining intensity did not appear to vary with donor age. In addition, immunoprecipitation of tissue extracts revealed the presence of integrin alpha2 and confirmed the absence of beta2. Results from polymerase chain reactions were consistent with these findings.
CONCLUSIONS: A spectrum of integrin receptors that may have important roles in the cell-matrix interactions are demonstrated in the human trabecular meshwork. The repertoire identified in tissues is similar to that found in cultured cells except that the beta4 expression in tissues is lost in cultures.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10520215     DOI: 10.1076/ceyr.19.5.395.5297

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  16 in total

Review 1.  Extracellular matrix in the trabecular meshwork.

Authors:  Ted S Acott; Mary J Kelley
Journal:  Exp Eye Res       Date:  2008-01-25       Impact factor: 3.467

Review 2.  The role of integrins in the trabecular meshwork.

Authors:  Debjani Gagen; Jennifer A Faralli; Mark S Filla; Donna M Peters
Journal:  J Ocul Pharmacol Ther       Date:  2013-11-23       Impact factor: 2.671

Review 3.  Extracellular matrix in the trabecular meshwork: intraocular pressure regulation and dysregulation in glaucoma.

Authors:  Janice A Vranka; Mary J Kelley; Ted S Acott; Kate E Keller
Journal:  Exp Eye Res       Date:  2015-04       Impact factor: 3.467

4.  Myocilin, a glaucoma-associated protein, promotes cell migration through activation of integrin-focal adhesion kinase-serine/threonine kinase signaling pathway.

Authors:  Heung Sun Kwon; Stanislav I Tomarev
Journal:  J Cell Physiol       Date:  2011-12       Impact factor: 6.384

Review 5.  The role of integrins in glaucoma.

Authors:  Mark S Filla; Jennifer A Faralli; Jennifer L Peotter; Donna M Peters
Journal:  Exp Eye Res       Date:  2016-05-13       Impact factor: 3.467

Review 6.  The changing paradigm of outflow resistance generation: towards synergistic models of the JCT and inner wall endothelium.

Authors:  Darryl R Overby; W Daniel Stamer; Mark Johnson
Journal:  Exp Eye Res       Date:  2008-12-11       Impact factor: 3.467

7.  Recent Developments in Understanding the Role of Aqueous Humor Outflow in Normal and Primary Open Angle Glaucoma.

Authors:  Cheryl R Hann; Michael P Fautsch
Journal:  Curr Ophthalmol Rep       Date:  2015-06-01

Review 8.  Functional properties of fibronectin in the trabecular meshwork.

Authors:  Jennifer A Faralli; Marie K Schwinn; Jose M Gonzalez; Mark S Filla; Donna M Peters
Journal:  Exp Eye Res       Date:  2008-09-18       Impact factor: 3.467

9.  Identification of the active site in the heparin II domain of fibronectin that increases outflow facility in cultured monkey anterior segments.

Authors:  Jose M Gonzalez; Yujie Hu; B'Ann T Gabelt; Paul L Kaufman; Donna M Peters
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-29       Impact factor: 4.799

Review 10.  Aqueous outflow regulation - 21st century concepts.

Authors:  Murray Johnstone; Chen Xin; James Tan; Elizabeth Martin; Joanne Wen; Ruikang K Wang
Journal:  Prog Retin Eye Res       Date:  2020-11-17       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.